SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Somatogen (SMTG) -- Ignore unavailable to you. Want to Upgrade?


To: R. M. Rosenthal who wrote (387)2/9/1998 10:59:00 AM
From: aknahow  Read Replies (1) | Respond to of 442
 
I think a deal with Amgen would be viewed very favorably.<g> Obviously the details of any deal with anyone are important factors in determination of the markets reaction. Great deals do not always keep a stock up, CBMI comes to mind. I think SMTG would at least return to past levels if they made a deal with Amgen.

A deal with a large Pharma without manufacturing facilities nearby, IMO would not be as favorable for the stock.